ATE173626T1 - Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis - Google Patents

Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis

Info

Publication number: ATE173626T1
Authority: AT; Austria
Prior art keywords: pancreatitis; treatment; producing; medicinal product; tocopheryl phosphate
Prior art date: 1994-08-05

Application number

AT95112104T

Other languages

English (en)

Inventor

Kazumi Ogata

Takahiro Sakaue

Shinya Ogino

Sachiko Matsuura

Rie Nagao

Original Assignee

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-05

Filing date

1995-08-01

Publication date

1998-12-15

1995-08-01 Application filed by Senju Pharma Co filed Critical Senju Pharma Co

1998-12-15 Application granted granted Critical

1998-12-15 Publication of ATE173626T1 publication Critical patent/ATE173626T1/de

Links

206010033645 Pancreatitis Diseases 0.000 title abstract 3
IOZWJJBOYMUHEJ-HMQIKIGCSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] hydrogen phosphate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OP(O)(=O)OC1=C(O)[C@@H]([C@@H](O)CO)OC1=O IOZWJJBOYMUHEJ-HMQIKIGCSA-N 0.000 title 1
229940115445 ascorbyl tocopheryl phosphate Drugs 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
-1 diester compound Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT95112104T 1994-08-05 1995-08-01 Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis ATE173626T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP18428294		1994-08-05

Publications (1)

Publication Number	Publication Date
ATE173626T1 true ATE173626T1 (de)	1998-12-15

Family

ID=16150598

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95112104T ATE173626T1 (de)	1994-08-05	1995-08-01	Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis

Country Status (8)

Country	Link
US (1)	US5650404A (de)
EP (1)	EP0699440B1 (de)
KR (1)	KR960006915A (de)
AT (1)	ATE173626T1 (de)
CA (1)	CA2152693A1 (de)
DE (1)	DE69506197T2 (de)
ES (1)	ES2124477T3 (de)
TW (1)	TW317500B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6703384B2 (en) *	1998-09-23	2004-03-09	Research Development Foundation	Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
EP1115398B1 (de) *	1998-09-23	2010-05-05	Research Development Foundation	Tocopherole, tocotrienole, sonstige chroman- und seitenkettenderivate, sowie deren verwendungen
EP1254130B1 (de) *	2000-02-11	2008-01-02	Research Development Foundation	Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung
WO2002026238A1 (en) *	2000-09-26	2002-04-04	Vital Health Sciences Pty Ltd.	Phosphate derivative supplements
AUPR549901A0 (en)	2001-06-06	2001-07-12	Vital Health Sciences Pty Ltd	Topical formulation containing tocopheryl phosphates
BR0211673A (pt)	2001-07-27	2004-07-13	Vital Health Sciences Pty Ltd	Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
US20030236301A1 (en) *	2001-12-19	2003-12-25	Bob Sanders	Liposomal delivery of vitamin E based compounds
AU2002950713A0 (en)	2002-08-09	2002-09-12	Vital Health Sciences Pty Ltd	Carrier
ATE495730T1 (de)	2004-03-03	2011-02-15	Vital Health Sciences Pty Ltd	Alkaloid-formulierungen
EP2548581A3 (de)	2005-06-17	2013-02-20	Vital Health Sciences Pty Ltd.	Träger mit einem oder mehreren Di- bzw. Mono-(Elektrontransfermittel) Phosphatderivaten oder Komplexen davon
WO2007070981A1 (en) *	2005-12-23	2007-06-28	Vital Health Sciences Pty Ltd	Compounds having cytokine modulating properties
AU2011213557B2 (en)	2010-02-05	2015-05-07	Phosphagenics Limited	Carrier comprising non-neutralised tocopheryl phosphate
MX2012011355A (es)	2010-03-30	2012-11-30	Phosphagenics Ltd	Parche de suministro transdermico.
RU2425669C1 (ru) *	2010-04-13	2011-08-10	Общество С Ограниченной Ответственностью "Гамаветфарм"	Средство для профилактики и лечения острого и хронического панкреатита
WO2012122586A1 (en)	2011-03-15	2012-09-20	Phosphagenics Limited	New composition
CN114712308A (zh)	2015-12-09	2022-07-08	磷肌酸有限公司	药物制剂
EP3558903B1 (de)	2016-12-21	2024-07-03	Avecho Biotechnology Limited	Verfahren zur phosphorylierung eines komplexen alkohols
EP4034137A4 (de) *	2019-09-27	2023-09-20	Duke University	Zusammensetzungen und verfahren zur prävention und behandlung von pankreatitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59219295A (ja) *	1983-05-30	1984-12-10	Senjiyu Seiyaku Kk	リン酸ジエステルまたはその塩およびそれらの製造法
JPS62145019A (ja) *	1985-12-19	1987-06-29	Senjiyu Seiyaku Kk	抗炎症剤
JPS62205091A (ja) *	1986-03-04	1987-09-09	Senjiyu Seiyaku Kk	新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JP2526059B2 (ja) *	1987-04-28	1996-08-21	千寿製薬株式会社	抗潰瘍剤
PH25859A (en) *	1988-01-11	1991-12-02	Takeda Chemical Industries Ltd	Composition for treatment of ischemic disorder
JP2854631B2 (ja) *	1989-11-21	1999-02-03	千寿製薬株式会社	糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤

1995
- 1995-06-27 CA CA002152693A patent/CA2152693A1/en not_active Abandoned
- 1995-06-28 TW TW084106619A patent/TW317500B/zh active
- 1995-07-18 US US08/503,722 patent/US5650404A/en not_active Expired - Fee Related
- 1995-08-01 AT AT95112104T patent/ATE173626T1/de not_active IP Right Cessation
- 1995-08-01 EP EP95112104A patent/EP0699440B1/de not_active Expired - Lifetime
- 1995-08-01 DE DE69506197T patent/DE69506197T2/de not_active Expired - Fee Related
- 1995-08-01 ES ES95112104T patent/ES2124477T3/es not_active Expired - Lifetime
- 1995-08-05 KR KR1019950024260A patent/KR960006915A/ko not_active Abandoned

Also Published As

Publication number	Publication date
EP0699440A1 (de)	1996-03-06
EP0699440B1 (de)	1998-11-25
CA2152693A1 (en)	1996-02-06
KR960006915A (ko)	1996-03-22
US5650404A (en)	1997-07-22
ES2124477T3 (es)	1999-02-01
TW317500B (de)	1997-10-11
DE69506197D1 (de)	1999-01-07
DE69506197T2 (de)	1999-04-15

Similar Documents

Publication	Publication Date	Title
ATE173626T1 (de)	1998-12-15	Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis
DE69512925D1 (de)	1999-11-25	Ortho-substituierte aromatische ether und ihre verwendung in schmerzstillenden pharmazeutischen zusammensetzungen
MY117896A (en)	2004-08-30	Quinazoline derivatives
IL120584A (en)	2003-10-31	1,2-diphenylpyrrole derivatives, use thereof for the manufacture of a medicament and pharmaceutical compositions containing the same
TWI255807B (en)	2006-06-01	Therapeutic agents
BG104561A (en)	2001-01-31	Aryl fused azapolycyclic compounds
ATE253918T1 (de)	2003-11-15	Verwendung von hymenialdisin und dessen derivaten zur herstellung therapeutischer mittel
ATE523194T1 (de)	2011-09-15	Bis(thiohydrazidamide) in kombination mit taxol für die behandlung von krebs
ATE206926T1 (de)	2001-11-15	Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne
DE69019111D1 (de)	1995-06-08	Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
PT781766E (pt)	2004-07-30	Derivado heterociclico e medicamento
ATE141508T1 (de)	1996-09-15	Zusammensetzung zur förderung des lipidmetabolismus
MX9804226A (es)	1998-09-30	Derivados novedosos de 2,3,5-trimetil-4-hidroxianilida, su preparacion y su aplicacion de terapeutica.
DE69428325D1 (de)	2001-10-25	Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
ATE367387T1 (de)	2007-08-15	Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
ATE123944T1 (de)	1995-07-15	Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
ATE170852T1 (de)	1998-09-15	Benzolsulfonamid-derivate zur behandlung der blaseninstabilität
ATE156359T1 (de)	1997-08-15	Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis
BG104983A (en)	2001-09-28	Aryl fused azapolycyclic compounds
FI935800A0 (fi)	1993-12-22	Antidepressiva och mot Parkisons sjukdom verksamma foereningar
DE69501359D1 (de)	1998-02-12	Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69805305D1 (de)	2002-06-13	Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69837334D1 (de)	2007-04-26	Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
DE69518159D1 (de)	2000-08-31	Mittel zur vorsorge und heilung von typ i allergischen krankheiten
HUP0001773A2 (hu)	2000-11-28	Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények

Legal Events

Date	Code	Title	Description
1999-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties